Jeiry Filian

International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib.

Michael W. Deininger, Stephen G. O’Brien, François Guilhot et al. · Blood · 2009 · 620 citations

Pharmacy, Hematology, Pharmacotherapy +12

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

Michiel S. van der Heijden, Guru Sonpavde, Thomas Powles et al. · New England Journal of Medicine · 2023 · 462 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

International Randomized Study of Interferon Versus STI571 (IRIS) 7-Year Follow-up: Sustained Survival, Low Rate of Transformation and Increased Rate of Major Molecular Response (MMR) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CMLCP) Treated with Imatinib (IM)

Stephen G. O’Brien, François Guilhot, John M. Goldman et al. · Blood · 2008 · 173 citations

Pharmacy, Oncology, Pharmacotherapy +8

Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8

Guy Jérusalem, Aleix Prat, Roberto Salgado et al. · The Breast · 2023 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Effects of Yogurt and Applesauce on the Oral Bioavailability of Nilotinib in Healthy Volunteers

Ophelia Yin, Marc S. Rudoltz, Ivana Galetić et al. · The Journal of Clinical Pharmacology · 2011 · 15 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17